HtrA serine proteases in cancers: A target of interest for cancer therapy

Biomed Pharmacother. 2021 Jul:139:111603. doi: 10.1016/j.biopha.2021.111603. Epub 2021 May 8.

Abstract

The HtrA protein family is composed by evolutionally-conserved serine proteases, which are homologous to the HtrA protein of the model bacterium Escherichia coli. They are widely distributed in organisms including humans, prokaryotes and eukaryotes. Moreover, HtrA family proteins are important regulators of a variety of human physiological processes, which contains the maintenance of mitochondrial homeostasis, cellular signal transduction and apoptosis regulation. The HtrA family has been found to be associated with cancer and could be used as a target for future cancer treatments. The purpose of this article is to review the relationship between these HtrA and cancer and to summarize the latest researches on HtrA and cancer.

Keywords: Cancers; HtrA1; HtrA2; HtrA3; HtrA4.

Publication types

  • Review

MeSH terms

  • Animals
  • Apoptosis / physiology
  • Homeostasis / physiology
  • Humans
  • Mitochondria / metabolism
  • Neoplasms / metabolism*
  • Serine Proteases / metabolism*
  • Signal Transduction / physiology

Substances

  • Serine Proteases